Urolithiasis 2

Front Matter....Pages i-xxx
Front Matter....Pages 1-1
Genetic Influences on Urinary Calcium Excretion....Pages 3-8
Role of Hydroxypyruvate in the Manifestation of Primary Hyperoxaluria L-Glyceric Aciduria Type-II....Pages 9-12
Mechanisms for Bi-Directional Oxalate Transport Across the Large Intestine....Pages 13-15
Sodium-Chloride-Dependent Oxalate Absorption in the Human Intestine....Pages 17-21
Erythrocyte Urate Self-Exchange in Idiopathic Calcium Nephrolithiasis....Pages 23-24
A New Chordate Model for Uric Acid-Oxalate Lithiasis....Pages 25-28
Renal Epithelial Injury: A Risk Factor in Urolithiasis....Pages 29-33
Oxalate Transport Across The Renal Papilla: Implications in Sites and Mechanism of Initial Kidney Stone Formation....Pages 35-39
Oxalate Transport in LLC-PK1 Cells: Evidence for Oxalate Transport by Anion Exchange....Pages 41-45
Polarized Distribution of Oxalate Transport Systems in A Line of Renal Epithelial Cells (LLC-PK1)....Pages 47-51
Endogenous Synthesis of Oxalate in Magnesium Deficient Weanling Rats....Pages 53-57
Increased Hepatic Oxalate Production in Rats Treated With Clofibrate....Pages 59-63
Hyperoxaluria in Nutritional Deficiencies of Vitamins and Magnesium in Idiopathic Calcium Oxalate Urolithiasis....Pages 65-69
Reduction of Urinary Oxalate Excretion by The Oral Administration of The Cysteine Precursor, 2-Oxothiazolidine-4-Carboxylic Acid....Pages 71-75
Acute Effects of Alkali And Earth Alkali Citrates in Humans — A Synopsis of Preliminary Data in Urine....Pages 77-78
Glycolate and Oxalate Plasma Levels and Renal Handling in Patients With Type 1 Primary Hyperoxaluria....Pages 79-79
Effect of High Dose Vitamin C on Urinary Oxalate Levels....Pages 80-80
Pathophysiology of Incomplete Renal Tubular Acidosis. Evaluation of Bone Turnover....Pages 81-81
Enzyme Changes in Experimental Models on Administration of Ip Oxalate....Pages 82-82
Uric Acid Metabolism in Calcium Oxalate Stone Disease....Pages 83-83
Front Matter....Pages 1-1
Effect of Caffeine-Loading on Urinary Calcium in Control Subjects and Recurrent Calcium Oxalate Stone Formers with Hypercalciuria....Pages 84-84
Tea — A Recommendable Beverage in Calcium Oxalate Urolithiasis?....Pages 85-85
Bone Mineral Content in Renal Stone Former (RSF) Patients With Idiopathic Hypercalciuria....Pages 86-86
Sensitive High-Performance Liquid Chromatographic Microassay for Human Liver L-Glutamate: Glyoxylate Aminotransferase Activity....Pages 87-87
Urinary Excretion of Citrate and Female Steroid Hormones....Pages 88-88
Distal Renal Tubular Acidosis: A Causative Factor of Nephrolithiasis in Northwestern India....Pages 89-89
Sex-Dependent Urolithiasis in The Portocaval Shunt Rat....Pages 90-90
Scanning Electron Microscopic Studies of Erythrocytes From Vitamin B 6 Deficient Rats and Vitamin B 6 Deficient Rats Fed With Galactose....Pages 91-91
In Primary Hyperparathyroidism Due to Adenomas, Post-Operative Hypocalcemia is Not Influenced by Histology of Remaining Glands....Pages 92-92
Renal Tubular Acidosis in Urinary Stone Disease....Pages 93-93
Case Report: Hyperoxaluria and Dietary Calcium....Pages 94-94
Front Matter....Pages 95-95
Vectorial Oxalate Transport Across a Monolayer of Renal Epithelial Cells (LLC-PK1)....Pages 97-99
Isolation and Characterization of Oxalate Decarboxylase From Human Intestine Bacteria....Pages 101-103
Oxalate Concentration in Rat Plasma Determined by in Vivo Isotopic Dilution and Enzymic Analysis....Pages 105-106
Abnormal Erythrocyte Oxalate Self-Exchange in Idiopathic Stone Formers is Not Linked with Chromosome 17....Pages 107-108
The Effect of Dietary Protein and Glucagon on the Urinary Excretion of Oxalate in the Guinea Pig....Pages 109-111
Macro and Micro Autoradiographic Studies on Oxalate in Normal and Hyperoxaluric Rats....Pages 113-115
Oxalate-Induced Changes in Intracellular Calcium Levels in Renal Papillary Cells....Pages 117-119
Oxalate: Bicarbonate Exchange on the Brush Border Membrane of Rat Proximal Tubules....Pages 121-123
Oxalate Uptake in a Human Intestinal Epithelial Cell Line, Caco-2....Pages 125-128
Front Matter....Pages 95-95
Control of Endogenous Oxalate Formation in Rats Administered Immobilized Glyoxylate Reductase....Pages 129-131
Enhancement of Urinary Oxalate Excretion by Vitamin C: Fact or Artifact ?....Pages 133-135
Erythrocyte Band 3 Protein Phosphorylation Modulates Anion Transport in Nephrolithiasic Patients....Pages 137-138
Calcium Phosphate Urolithiasis in the Male Rat — Evidence For Enteric Hyperoxaluria as one Associated Anomaly....Pages 139-140
Oxalate Clearances in Calcium Oxalate Stone Forming Patients....Pages 141-141
Transepithelial Oxalate Transport in Cultured Renal Cells....Pages 142-142
Plasma and Urinary Oxalate and Glycolate in Normal Subjects and Idiopathic Calcium Stone Formers....Pages 143-143
Oxalate Uptake in Right-Side-Out Erythrocyte Vesicles of Control and Pyridoxine Deficient Rats....Pages 144-144
Primary Hyperoxaluria Type 2: Specific and Simple High-Performance Liquid Chromatographic Determination for L -Glyceric Acid in Body Fluids....Pages 145-145
Transmembrane Oxalate Flux Studies in Intact Erythrocytes of Magnesium-Deficient Rats....Pages 146-146
Erythrocyte Oxalate Self-Exchange Rates in Japan....Pages 147-147
Front Matter....Pages 149-149
Crystal Growth and Nucleation Rates for Calcium Oxalate in 92% Fresh Urine in a Continuous Crystalliser....Pages 151-153
Inhibitory Action of Citrate on Calcium Oxalate Monohydrate Crystal Nucleation and Growth....Pages 155-158
A New Continuous Flow Microsystem of Crystallization in Gels as a Model of Urinary Stone Formation....Pages 159-160
Formation of Urinary Stones in Vitro : Growth of Calcium Oxalate on Spherulites of Calcium Phosphate in Gel....Pages 161-165
Calcium Oxalate Crystallization in Long, Thin Tubes....Pages 167-172
A General Aggregation Mechanism for Calcium Oxalate....Pages 173-178
Urinary Citrate and Urate Modulate Calcium Oxalate Monohydrate Solubility and Agglomeration....Pages 179-180
Heterogeneous Deposition of Calcium Phosphates at the Silicon (Hydrous) Oxide — Water Interface....Pages 181-183
The Inhibitory Effect of Urinary Heparan Sulfate and Chondroitin Sulfate on Calcium Oxalate Crystal Growth....Pages 185-187
Front Matter....Pages 149-149
The Effect of Glycosaminoglycans on Calcium Oxalate Monohydrate Crystal Morphology....Pages 189-191
Urinary Glycosaminoglycans Differ in their Calcium Oxalate Crystallization Activities....Pages 193-195
The Effect of Urate on Calcium Oxalate Precipitates....Pages 197-199
The Promotion of Calcium Oxalate Crystallization by Urate: Can it be that Epitaxy is Not the Cause After All?....Pages 201-203
Effects of Urinary Macromolecules on Calcium Oxalate Crystallization Studied by Continuous Flow System and Fresh Undiluted Urine....Pages 205-207
Studies of Urinary Macromolecules: an Urgent Appeal for a Standard Reference Crystallization Model....Pages 209-210
Studies of Calcium Oxalate Stone Formation: Introducing a Multi - Faceted Crystalliser....Pages 211-212
Effects of Citrate and Urinary Macromolecules on Crystal Aggregation....Pages 213-214
Influence of Ionic Strength on Crystal Adsorption and Inhibitory Activity of Macromolecules....Pages 215-216
Influence of Ammonium Concentration and Anion Gap on Relative Supersaturations in the Urine of Stone Forming Patients....Pages 217-218
Calcium Carbonate Crystals Promote Epitaxial Calcium Oxalate Crystal Growth....Pages 219-220
Effects of Glycosaminoglycans on Experimental Urolithiasis in Rats....Pages 221-222
Oral Cimetidinein Humans - Evidence For Urine Acidification and Inhibition of Calcium Oxalate Crystallization....Pages 223-224
Computer Model of Complexation Inhibitors of Calcium Oxalate Stone Formation....Pages 225-225
Dual Constant Composition Studies of the Simultaneous Growth and Dissolution of Calcium Oxalate and Calcium Phosphate....Pages 226-226
Current Concepts and Future Trends in Urolithiasis Research with Special Reference to Molecular Basis of Disease....Pages 227-227
Inhibitors of Urinary Stone Formation in Controls and Stone Formers....Pages 228-228
Phosphocitrate as an Inhibitor of Calcium Oxalate Crystallization in Vivo ....Pages 229-229
Relationships Between Inhibitor Structure and Its Effects on Calcium Oxalate Monohydrate Crystallization Kinetics....Pages 230-230
Microdetermination of Crystal Growth Rates of Calcium Oxalate in Gel at Inverse Distribution of Components....Pages 231-231
Front Matter....Pages 149-149
Phosphate Crystal Growth in Vitro - the Mix Up....Pages 232-232
Growth Studies of Calcium Oxalate in Presence of Inhibitor....Pages 233-233
Natural Urine Versus Synthetic Urine for Studying Inhibitors....Pages 234-234
Growth of Uric Acid Crystals in Vitro ....Pages 235-235
Purity of Crystals Grown in Vitro in the Presence of Dopants....Pages 236-236
Does Ostwald Ripening of Calcium Oxalate Crystals Occur in Vitro ?....Pages 237-237
Citrate — A Strong Inhibitor of Urease-Induced Crystallization in Urine....Pages 238-238
Urine Polyanionic Inhibitors in Saudi Stone Formers and Normal Controls....Pages 239-239
The Effect of Kanpou Medicines on the Growth and Aggregation of Calcium Oxalate Crystals in Vitro ....Pages 240-240
Controlled Release of Phosphocitrate Inhibits Mixed Stone Growth....Pages 241-241
Determination of Rare Earth Elements in Urinary Stones by Instrumental Neutron Activation Analysis (INAA)....Pages 242-242
Anticalculogenic Properties of Scoparia dulcis Linn ....Pages 243-243
Front Matter....Pages 245-245
Possible Role of Stone Matrix in Calcium Oxalate Stone Formation....Pages 247-252
Role of Uropontin in Urinary Calcium Stone Formation....Pages 253-258
Distribution and Quantification of Crystal Matrix Protein in the Human Kidney....Pages 259-264
Localization of Nephrocalcin in the Nephron....Pages 265-270
In Undiluted Human Urine Tamm-Horsfall Mucoprotein Mitigates the Promotion of Calcium Oxalate Crystallization Induced by Urate....Pages 271-274
Evidence that Uric Acid Abolishes Citrate-Mediated Inhibition of Calcium Oxalate Monohydrate Agglomeration in Vitro ....Pages 275-279
Same Sequence Between Osteopontin and Urinary Stone Protein....Pages 281-283
Two-Dimensional Gel Analysis of Proteins in Unprocessed Human Urine Using Double Stain....Pages 285-286
Front Matter....Pages 245-245
Two-Dimensional Analysis of Proteins in the Urine of Male and Female Stone Formers....Pages 287-288
Crystal Matrix Protein — Sorting the Sexes....Pages 289-291
Studies on Urinary Proteins in Calcium Oxalate Stone Formation....Pages 293-295
Ultrafiltration of Human Urine Affects Calcium Oxalate Monohydrate (COM) Crystallization Kinetics....Pages 297-298
Nephrocalcin in Saudi Stone Formers and Normal Controls....Pages 299-301
Inhibition of Calcium Oxalate Crystal Aggregation by Tamm-Horsfall Glycoprotein Depends on Citrate....Pages 303-305
Human Kidney Produces a Protein Similar to Lithostathine, the Pancreatic Inhibitor of CaCO 3 Crystal Growth....Pages 307-309
Study of Tamm-Horsfall Glycoprotein Binding to Calcium Oxalate Monohydrate Crystals....Pages 311-312
Crystal Matrix Protein: a Potent Inhibitory Component of Calcium Oxalate Crystals....Pages 313-313
Two-Dimensional Electrophoretic Analysis of Unprocessed Human Bladder Washings: an Evaluation of Urothelial Proteins in Patients with Normal Bladder Mucosa....Pages 314-314
Isolation and Partial Characterisation of Renal Stone Proteins....Pages 315-315
Factors Affecting the Inclusion of Crystal Matrix Protein Into Calcium Oxalate Crystals: Centrifugation, Sieving and Sex....Pages 316-316
Quantification of Mineral Encrustation of Catheter Materials in a Flow System of Crystallization....Pages 317-317
Nephrocalcin in Children with Calcium Oxalate Stone Disease....Pages 318-318
Front Matter....Pages 319-319
Role of Organic Matrix in the Formation and Growth of Calcium Oxalate Urinary Stones....Pages 321-323
Calcium Oxalate Crystals and Oxalate Ions are Injurious to Renal Epithelial Cells....Pages 325-327
The Protein Content of Urinary Calculi in Chinese Patients....Pages 329-331
The Prevention of Experimental Nephrocalcinosis With Eicosapentaenoic Acid (Epa) And Evening Primrose oil (GLA)....Pages 333-334
Incidence and Formation of Mixed Kidney Stones Containing Calcium Oxalate and Uric Acid....Pages 335-337
Preliminary Result of Calcium Oxalate Crystal Interaction With Madin-Darby Canine Kidney Cells in Culture....Pages 339-341
Front Matter....Pages 319-319
Inhibition of Calcium Oxalate Monohydrate Seed Crystal Growth is Decreased in Renal Injury....Pages 343-345
Do Bacterial Membranes Contribute to Calcium Oxalate (Caox) Crystal Deposition?....Pages 347-349
Calcium Oxalate Crystallizing Properties of Macromolecules Released by Renal Tubular Cells in Vitro ....Pages 351-353
Exaggerated Response of the Hyper-Oxaluric Stone Former to an Oxalate Load Test at Initial Metabolic Evaluation....Pages 355-357
Fibrous Matrix in Experimental Urolithiasis....Pages 359-361
Analysis of the Protein Content of Five Different Types of Kidney Stones....Pages 363-364
Long Term Studies of Urease-Induced Crystallization in Human Urine....Pages 365-365
Oxalate Crystalluria for Post-Hepatic and Renal Transplantation Management in Primary Hyperoxaluria....Pages 366-366
Is Infra-Red (IR) Analysis an Alternative to Chemical Analysis?....Pages 367-367
Calcium Oxalate Crystal Matrix-What About the Glycosaminoglycans?....Pages 368-368
Part 1. A Refined Etiological Classification of Calcium Oxalate Urolithiasis Based on Calculi Studies....Pages 369-369
Part II: Morpho-Constitutional Analysis (MCA) of Calculi in Hyperparathyroidism, Distal Renal Tubular Acidosis, and Primary Hyperoxaluria....Pages 370-370
Front Matter....Pages 371-371
Urinary Silicate in Calculous Patients....Pages 373-374
Recurrent Renal Calculi in Patients with Medullary Sponge Kidney....Pages 375-378
Effect of Various Types of Animal Protein in Lithogenesis....Pages 379-381
Effect of Caffeine Consumption on Urinary Calcium, Magnesium, Oxalate and Citrate in Calcium Stone Formers....Pages 383-385
Should Hypercalciuria be Redefined?....Pages 387-389
Comparison of Acute and Chronic Calcium-Load Tests in Renal Stone Formers....Pages 391-393
Circadian Rhythmometric Studies on the Low Molecular Weight Urinary Inhibitors of Calcium Oxalate Urolithiasis....Pages 395-397
Relationship Between 24 Hour Urinary Volume, Urinary Specific Gravity, and Relative Super-Saturations in Stone Forming Patients....Pages 399-401
Front Matter....Pages 371-371
The Bonn Urolithiasis Post-Episode Care Program — New Results....Pages 403-405
The Oxalate Content of Sesame Seeds and Related Foods....Pages 407-408
Changes of Serum and Urine Parameters in Immobilized Children and Adolescents....Pages 409-409
Stone Formation Risk Index(SFRI): A Possible Prognostic Factor Governing the Need for Metaphylaxy....Pages 410-410
Urolithiasis in Diabetes Mellitus....Pages 411-411
Renal Toxicity Induced in Rats by Oral Sodium Oxalate....Pages 412-412
New Insights About Diet and Nephrolithiasis in an Obese Population....Pages 413-413
ATP Depletion: A Possible Role in the Pathogenesis of Uric Acid Nephrolithiasis in the Elderly....Pages 414-414
Relative Hypoparathyroidism and Calcitriol Up-Regulation in Idiopathic Hypercalciuria....Pages 415-415
Changes of Serum and Urine Parameters in Immobilized Adults....Pages 416-416
Effect of a Vegetarian Diet on Urinary Oxalate Excretion in Healthy Subjects....Pages 417-417
Calcium Oxalate Supersaturation of Urine: Which Factors should be Measured?....Pages 418-418
Urinary Fibrinolytic Activity of Stone Formers — Does Diet Matter?....Pages 419-419
Chronobiology of Urinary Volume, Calcium, Oxalate and Uric Acid in Stone Formers and Healthy Subjects....Pages 420-420
Involvement of Tubular Injury in Stone Formation: Experimental Investigations....Pages 421-421
Chemical Composition of the Urine in the Normal Black and White Population....Pages 422-422
Effect of Drastic Dehydration on Urine Lithogenic Risk Factors in Normal Humans....Pages 423-423
Does Sialic Acid Possibly Influence Stone Formation?....Pages 424-424
The Relationship Between Urinary Ca 2+ , pH and Stone Disease....Pages 425-425
Oxalate Crystalluria — A Disease....Pages 426-426
Front Matter....Pages 371-371
Urinary Citrate in Relation to Dietary Citrate....Pages 427-427
Clinical Significance of Hypocitraturia....Pages 428-428
Urinary Saturation in Patients with Inflammatory Bowel Disease....Pages 429-429
Urinary Calcium and Uric Acid Excretion in Patients with Multiple Calculi Elimination....Pages 430-430
Coffee and Tea Consumption — Risk for Urolithiasis....Pages 431-431
Computerised Dietetic Survey....Pages 432-432
Risk of Calcium Stone Formation in Relation to Sex....Pages 433-433
Effects of Dietary Nutrients Upon Urinary Excretion of Calcium, Uric Acid and Citrate in Renal Stone Formers....Pages 434-434
Increased Risk of Calcium Oxalate Stones in Young Females....Pages 435-435
Front Matter....Pages 437-437
Oxalate-Degrading Bacteria in the Gut -Do They Influence Calcium Oxalate Stone Formation?....Pages 439-441
Urinary Enzymes: Their Role in Renal Stone Formation....Pages 443-444
Urolithiasis in Turkey: Epidemiological Features and Causal Factors of Stone Formation....Pages 445-447
Liquor in Lithogenesis....Pages 449-451
Epidemiology of Urinary Stone Disease in Saudi Arabia....Pages 453-455
An Epidemiological Study of Upper Urinary Stones in Kaizuka City....Pages 457-459
Experimental Bladder-Stone Production in Rats by Ureaplasma Urealyticum ....Pages 461-464
Composition of Urinary Calculi In the South of Portugal....Pages 465-467
The Influence of Diet on Urinary Risk Factors for Stones in Idiopathic Calcium Stone Formers and Healthy Subjects....Pages 469-469
The Drinking Water Link Between Endemic Renal Stones, Fluorosis and Goitre: an Epidemiological Study....Pages 470-470
Oxalate, Glycolate and Glyoxylate Excretion in Saudi Stone Formers and Normal Controls....Pages 471-471
Front Matter....Pages 437-437
Calcium Oxalate Stone Disease in Children....Pages 472-472
Hypokaliuric — Hypocitraturic Nephrolithiasis: a Unique Clinical Entity of Northeast Thailand....Pages 473-473
The Dissolution of Infective Stone Salts by Citrate Solutions Using a Reproducible Model of Catheter Encrustation....Pages 474-474
Laboratory Analysis and Clinical Results of the Treatment of Struvite Stones: a Ten-Year Study....Pages 475-475
Comparative Methods for Urine Culture Collection: Sterilized Glass Tube Versus Disposable Plastic Cup....Pages 476-476
Results of Family Studies in Cystine Calculus Follow-Up....Pages 477-477
Urinary Tract Infection in Idiopathic Calcium Nephrolithiasis....Pages 478-478
Risk of Urolithiasis in Gulf-Returned Keralites....Pages 479-479
The Brazilian Multicentric Study of Nephrolithiasis (Multilit)....Pages 480-480
Characterization of a Referred Population to a Northern-California Stone Clinic....Pages 481-481
Recurrence of Upper-Urinary-Tract Stones in Northeast Thailand....Pages 482-482
Etiogenic Factors for Calcium Oxalate Lithiasis in Southwestern Macedonia....Pages 483-483
Front Matter....Pages 485-485
Ultrasound Velocity — A Measure of Stone Strength?....Pages 487-491
Effect of Medical Management and Residual Fragments on Recurrent Stone Formation Following Extra-Corporeal Shock Wave Lithotripsy....Pages 493-497
Protective Effects of Verapamil on Shock Wave Induced Tubular Damage....Pages 499-502
Renal Morphological Damage and Its Accumulation by Repeated Extracorporeal Shock Waves....Pages 503-505
Ureteral Stones: The Results of Primary in Situ Eswl and Outpatients Procedure ....Pages 507-509
Treatment Philosophy and Re-Treatment Rates Following Piezoelectric Lithotripsy....Pages 511-513
GD-DTPA-Enhanced Dynamic MRI for Evaluation of Renal Damage After ESWL Treatment....Pages 515-516
Long-Term Results of Extracorporeal Shock Wave Lithotripsy, Percutaneous Nephrolithotomy and Open Surgery for Upper Urinary Tract Stone....Pages 517-519
Front Matter....Pages 485-485
Grey Scale Image Discrimination: an Accurate Method of Stone Targeting?....Pages 521-522
Shock Wave Lithotripsy in the Treatment of Urinary Stones in Renoureteral Anomalies....Pages 523-525
Lithoclast — A New Endolithotriptor....Pages 527-528
Hypertension after Extracorporeal Shock Wave Lithotripsy: Long Term Follow Up....Pages 529-531
ESWL Monotherapy for Staghorn Renal Calculi....Pages 533-534
Two Year Experience with the Lithoclast for Endolithotripsy....Pages 535-535
Electrohydraulic vs. Laser Lithotripsy: Is New Necessarily Better?....Pages 536-536
 In Situ Treatment of Ureteral Calculi with Extracorporeal Shockwave Lithotripsy — Still Feasible?....Pages 537-537
The Effect of High Energy Shock Waves on Oxalate Uptake in Cultured Renal Cells....Pages 538-538
Residual Stones Following Extracorporeal Shock Wave Lithotripsy — The Case for Citrate Prophylaxis....Pages 539-539
Sodium-Potassium Citrate in The Treatment of Residual Stone Fragments Resulting from Extra-Corporeal Shock Wave Lithotripsy....Pages 540-540
Extracorporeal Lithotripsy of Renal Calculi with the Storz Modulith™ SL20: A Multicenter Study....Pages 541-541
The Management of Ureteral Stones Using Extracorporeal Shock Wave Lithotripsy and Ureteroscopy....Pages 542-542
Extracorporeal Shockwave Lithotripsy for Staghorn Calculi....Pages 543-543
Experiential Improvements in Extra-Corporeal Lithotripsy on MPL 9000, An Ultrasound-Monitored Lithotriptor....Pages 544-544
The Enlargement of Residual Fragments after Extracorporeal Shock Wave Lithotripsy of Infection Stones: Urological Strategies and Pathogenetic Hypothesis....Pages 545-545
Radiological Characterisation of Urinary Stones....Pages 546-546
Urinary Red Blood Cell Microscopic Morphology after ESWL: A Parameter of Glomerular Damage....Pages 547-547
ESWL and Urinary Infection in Pretreatment of Non Infected Patients....Pages 548-548
 In Situ Extracorporeal Shock Wave Lithotripsy for Ureteral Stones....Pages 549-549
Front Matter....Pages 485-485
Ureteric Stones Managed by ESWL and Ureteroscopy (URS) under General Anaesthesia or Local Anaesthesia....Pages 550-550
The Electromechanical Impactor (EMI): A Device for Intracorporeal Lithotripsy....Pages 551-551
Laserlithotripsy....Pages 552-552
Renal Insufficiency after ESWL....Pages 553-553
Front Matter....Pages 555-555
Calcium Supplementation for Enteric Hyper-Oxaluria Secondary to Intestinal Bypass....Pages 557-561
Primary Hyperoxaluria: Long-Term Outcome in Patients Treated with Orthophosphate and Pyridoxine....Pages 563-566
The Clinical Spectrum of Ammonium Urate Renal Calculi....Pages 567-570
A New Therapeutic Agent for Cystinuria....Pages 571-574
The Treatment of Idiopathic Recurrent Urolithiasis With Fish Oil and Evening Primrose Oil — A Double-Blind Study....Pages 575-580
Simultaneous Treatment of Calcium Oxalate and Uric Acid Stone Disease in Saudi Arabia....Pages 581-586
Urinary Tract Stone After Ureterosigmoidostomy....Pages 587-589
Renal Targeting of Phosphocitrate Via a Gamma-Glutamyl Prodrug....Pages 591-593
Therapeutic Effect of Tribulus Terrestris (Chota Gokhru, an Ayurvedic Drug) in the Management of Experimental Hyperoxaluria....Pages 595-596
Metabolic Abnormalities in Patients With Renal Staghorn Stones....Pages 597-598
Effect of ACE Inhibitor on Cystine Excretion in Cystinuria....Pages 599-601
Treatment of Cystine Nephrolithiasis with Alpha-Mercapto-Propionylglycine....Pages 603-604
Influence of Total Parenteral Nutrition on Urinary Calcium Oxalate Saturation and the Development of Nephrocalcinosis in Preterm Infants....Pages 605-607
Value of Bone Mineral Analysis in Patients with Urolithiasis by Single Photon Absorptiometry, Dual Photon Absorptiometry, and Dual Energy X-Ray Absorptiometry — Comparison of Primary Hyperparathyroidism and Idiopathic Urolithiasis, and on the Possibility of Differentiating Idiopathic Hypercalciuria....Pages 609-611
Exaggerated Calciuric Response to an Acute Acid Load in Patients with Calcium Renal Lithiasis....Pages 613-615
Do Idiopathic Stone Formers Have Low Bone Mass?....Pages 617-618
Front Matter....Pages 555-555
Renal Handling of Citrate in Patients with Primary Hyperparathyroidism and Calcium Nephrolithiasis....Pages 619-621
Exogenous Calcitonin (CT) — A Probe for the State of Mineral Metabolism in Idiopathic Recurrent Calcium Urolithiasis (RCU)....Pages 623-626
Osteocalcin Response to Low Calcium Diet: A Helpful Tool for the Differential Therapy of Hypercalciuria....Pages 627-629
Influence of Morphologic and Urodynamic Factors on Calcium-Containing Stone Formation....Pages 631-633
Protective Effects of Calcium Antagonists on Vitamin-Induced Nephrolithiasis....Pages 635-637
Response to an Oral Calcium Load in Stone Formers, Their Spouses and First Degree Blood Relatives....Pages 639-641
Attenuation of Hypocalciuric Response to Long-Term Thiazide and Amiloride in Calcium Urolithiasis with Renal Hypercalciuria....Pages 643-644
Bone Effects of Calcium Restriction Diet in Children with Absorptive Hypercalciuria....Pages 645-646
Assessment of Nutrient Intake by Calcium Stone Former Patients....Pages 647-648
Incidence of Pouch Stones and Risk Factors for Urolithiasis in Patients Receiving Continent Diversion or Neobladder Using Intestine — Comparision with Ileal Conduit....Pages 649-650
Long-Term Results of Sodium-Potassium Citrate Therapy (Oxalyt-C R ) for Preventing Calcium Oxalate Stones....Pages 651-651
Dissolution of Calcium Calculi with Potassium Citrate....Pages 652-652
Alkali Citrate Metaphylaxis for Recurrent Calcium Oxalate Stone Formers — A Prospective Randomized Study....Pages 653-653
Innate Humoral Immunity in the Fight Against Post-Operative Sepsis: Is it Enough ?....Pages 654-654
Antibiotic Prophylaxis for Endourological Surgery — A New Twist....Pages 655-655
Blood Pressure in Idiopathic Calcium Nephrolithiasis....Pages 656-656
Beneficial Effect of Magnesium Oxide Administration on Calcium Oxalate Urolithiasis....Pages 657-657
Sodium Potassium Citrate in the Medical Management of Urolithiasis: A Universal Metaphylactic Agent?....Pages 658-658
The Day-to-Day Management of Stone Prophylaxis Using the Urimho Self-Test Device....Pages 659-659
Long Term Effect of Conservative Management....Pages 660-660
Front Matter....Pages 555-555
Role of Musapith in Urolithiasis....Pages 661-661
Diclofenac Sodium in Acute Ureteric Colic....Pages 662-662
Oral Citrate Therapy in Urolithiasis....Pages 663-663
Veeratharadi in Urolithiasis....Pages 664-664
Therapeutic Efficacy of Combined Supplementation of Magnesium and Pyridoxine in Calcium Oxalate Stone Formers....Pages 665-665
Therapeutic Role of Diclofenac-Sodium in Management of Hypocitraturia and Hypopyrophosphaturia in Idiopathic Stone Formers....Pages 666-666
Prophylactic Treatment of Recurrent Calcium Stones with Potassium Sodium Citrate....Pages 667-667
Dietary Moderation as a Means of Improving Urinary Risk Factors of Recurrent Calcium Oxalate Stone Formation....Pages 668-668
Influence of L-Methionine on the Risk of Struvite and Brushite Stone Formation....Pages 669-669
Hematuria Due to Hyperuricosuria (HU): 30 Months Follow-Up....Pages 670-670
Unilateral Hydronephrosis: DMSA and DTPA Scan in Renal Stone Formers....Pages 671-671
The Value of Repeated Analyses of 24 Hour Urine in Recurrent Calcium Urolithiasis....Pages 672-672
The Course of Urolithiasis over Fifteen Years in Calcium Oxalate Stone Formers under Special, General or No Metaphylaxis....Pages 673-673
Is There a Role for the Oral Calcium Tolerance Test in a Routine Stone Clinic?....Pages 674-674
Ambulatory Metabolic Evaluation of 1515 Stone Forming Patients in Argentina....Pages 675-675
The Weekend Effect....Pages 676-676
Ultra Sound Study Versus IV Urogram in Ureteric Colic....Pages 677-677
Local Chemolysis of Obstructive Uric Acid Stone by 0.1M Tham and 0.02% Chlorhexidine....Pages 678-678
Complex Therapy of Cystine Urolithiasis in 1992....Pages 679-679
 In Vitro Magnetic Resonance Scanning of Urinary Calculi....Pages 680-680
Front Matter....Pages 555-555
New Medical and Urological Management of Medullary Sponge Kidney Disease....Pages 681-681
Management of Encrustation of Indwelling Ureteral Stents....Pages 682-682
Staghorn Calculi (Sc): Long Term Follow-Up....Pages 683-683
Urinary Evaluation in Brazilian Renal Stone Former Patients....Pages 684-684
Back Matter....Pages 685-696